Lupus Service News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Alentis Therapeutics Appoints Prof David Jayne and Prof Josep Tabernero to its Scientific Advisory Board
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Kyverna Therapeutics to Present New Data of KYV-101 in Lupus at European Congress of Rheumatology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
ChemoCentryx Inc (CCXI) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble.
ChemoCentryx Inc (NASDAQ: CCXI)
Operator
Good day and thank you for standing by. Welcome to the ChemoCentryx First Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today s conference is being recorded. [Operator Instructions]
I would now like to hand the conference over to Lee Roth of Burns McClellan. Please go ahead, sir.SPONSORED:
10 stocks we like better than ChemoCentryx
ChemoCentryx to Host Virtual R&D Day on April 14, 2021
April 07, 2021 08:30 ET | Source: ChemoCentryx, Inc. ChemoCentryx, Inc. Mountain View, California, UNITED STATES
MOUNTAIN VIEW, Calif., April 07, 2021 (GLOBE NEWSWIRE) ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that it will host a virtual R&D Day on Wednesday, April 14, 2021 beginning at 12:30 p.m. ET. The event will feature a panel of key opinion leaders, a testimonial from a patient living with ANCA-associated vasculitis and members of the ChemoCentryx Management team. The event will focus on the Company’s upcoming milestones and developments in key pipeline programs.
Presenters:
Tausif (“Tosh”) Butt, Executive Vice President and Chief Operating Officer of ChemoCentryx
ChemoCentryx Announces Publication in The New England Journal of Medicine of Results of the Pivotal Phase III ADVOCATE Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.